EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+10.93%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$6.37B
AUM Growth
+$6.37B
(+4.1%)
Cap. Flow
+$9.1M
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
24.31%
Holding
176
New
24
Increased
63
Reduced
39
Closed
19
Top Buys
| 1 |
Old Dominion Freight Line
ODFL
|
$71.8M |
| 2 |
Trade Desk
TTD
|
$42.2M |
| 3 |
Copart
CPRT
|
$41.3M |
| 4 |
GitLab
GTLB
|
$40.6M |
| 5 |
Rollins
ROL
|
$39.5M |
Top Sells
| 1 |
CrowdStrike
CRWD
|
$80M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$60.1M |
| 3 |
Palo Alto Networks
PANW
|
$57.7M |
| 4 |
Cheniere Energy
LNG
|
$51.4M |
| 5 |
BILL Holdings
BILL
|
$42.7M |
Sector Composition
| 1 | Healthcare | 38.58% |
| 2 | Technology | 26.06% |
| 3 | Industrials | 16.52% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Communication Services | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Sarepta Therapeutics
SRPT
$1.95B
| $17.5M | 0.28% |
135,466
+46,247
| +52% | +$5.99M |
|
102
Insmed
INSM
$30.7B
| $17.2M | 0.27% |
635,185
| – | – |
|
103
Ultragenyx Pharmaceutical
RARE
$3.08B
| $16.8M | 0.26% |
359,000
| – | – |
|
104
IDEX
IEX
$12.1B
| $16.3M | 0.26% |
66,694
+12,051
| +22% | +$2.94M |
|
|
ALPN
105
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $16.2M | 0.25% |
+408,542
| New | +$16.2M |
|
106
Public Service Enterprise Group
PEG
$40.6B
| $15.5M | 0.24% |
+231,675
| New | +$15.5M |
|
107
IDEAYA Biosciences
IDYA
$2.3B
| $14.7M | 0.23% |
335,000
| – | – |
|
108
Verisk Analytics
VRSK
$37.3B
| $13.9M | 0.22% |
59,054
+12,499
| +27% | +$2.95M |
|
109
Rocket Pharmaceuticals
RCKT
$356M
| $13.2M | 0.21% |
490,732
| – | – |
|
|
JBIO
110
Jade Biosciences, Inc. Common Stock
JBIO
$248M
| $13.2M | 0.21% |
445,500
+433,322
| +3,558% | +$12.8M |
|
111
Alnylam Pharmaceuticals
ALNY
$59.3B
| $13M | 0.2% |
87,000
| – | – |
|
112
Veracyte
VCYT
$2.38B
| $12.5M | 0.2% |
564,000
| – | – |
|
113
Apellis Pharmaceuticals
APLS
$3.54B
| $12.3M | 0.19% |
209,794
| – | – |
|
114
Southern Company
SO
$101B
| $12.1M | 0.19% |
168,863
-142
| -0.1% | -$10.2K |
|
115
GXO Logistics
GXO
$5.84B
| $11.9M | 0.19% |
220,750
+580
| +0.3% | +$31.2K |
|
116
Diamondback Energy
FANG
$41.8B
| $11.8M | 0.19% |
59,524
-50,097
| -46% | -$9.93M |
|
117
Revolution Medicines
RVMD
$7.53B
| $11.6M | 0.18% |
361,000
| – | – |
|
118
Constellation Energy
CEG
$96.3B
| $11.6M | 0.18% |
+62,493
| New | +$11.6M |
|
119
NetApp
NTAP
$23.1B
| $11.1M | 0.17% |
+105,504
| New | +$11.1M |
|
120
TG Therapeutics
TGTX
$5.13B
| $10.9M | 0.17% |
718,814
+279,340
| +64% | +$4.25M |
|
121
908 Devices
MASS
$206M
| $10.8M | 0.17% |
1,430,995
| – | – |
|
122
Applied Industrial Technologies
AIT
$9.92B
| $10.3M | 0.16% |
+52,295
| New | +$10.3M |
|
123
Equinix
EQIX
$74.6B
| $10.2M | 0.16% |
12,357
+2,829
| +30% | +$2.33M |
|
124
CMS Energy
CMS
$21.4B
| $10.2M | 0.16% |
168,668
-110,412
| -40% | -$6.66M |
|
125
Sysco
SYY
$38.3B
| $9.76M | 0.15% |
120,249
| – | – |
|